The Archimedes system is designed to reduce the chances of dialysis patients developing peritonitis, an infection of the peritoneum caused by what is commonly referred to as “touch contamination,” Lindo said.

“When the patient opens up a new disposable tubing set and tries to connect it themselves, sometimes the patients will accidentally touch the end of the connector before they connect it to the port coming out of their abdomen. This can sometime cause an infection,” he said.

The answer to this potential problem was to design a disposable tubing set that Lindo’s team believes will drastically reduce the number of peritonitis cases. The Archimedes system is on wheels and can operate off a battery, making it more mobile, helping patients feel less trapped.

“If they want to start their therapy in their living room while watching TV or interacting with their family members, then they can wheel it into their bedroom and go to sleep, and the machine will continue to deliver the rest of their therapy while they are sleeping,” said Lindo, adding that the Archimedes system is less painful and easier to use for dialysis patients.

Oklahoma City’s reputation in the bioscience space has steadily grown in recent years with the addition of more companies and investment capital, resulting in more breakthrough discoveries and more jobs. The most recent estimates show that bioscience companies in Oklahoma City support 51,000 workers with total compensation of $2.2 billion.

This article originally appeared in the August 2021 edition of the VeloCity newsletter.